Reluma - Invitrx
Invitrx Therapeutics, Inc. (Invitrx) is NOT liable for the intended use of any of its products. Invitrx does not intend to define, suggest, alter or approve of any kind of "practice of medicine" performed by the administering physician(s) instead relying on the IND and/or Clinical Trial IRB to determine safe practices of use of the Cord Blood Stem Cell Product(s)(CBSC), Amniotic Fluid, Amniotic Tissue, Human Umbilical Cord Blood Plasma (hUCBP), Wharton's Jelly, and Wharton's Jelly (MSC).
Description
More Products & Services
Products & Services
Reluma Skin Care I Reluma Skin Care Official Site I Skin Care Science
Invitrx Therapeutics
Reluma Skin Care is formulated with growth factors and matrix proteins derived from our breakthrough Stem Cell Core Technology. From the experts in regenerative medicine and skin science come the future of skincare.
Invitrx Therapeutics
Invitrx Therapeutics
Our Process & Lab - Invitrx
Invitrx Therapeutics
Invitrx Therapeutics, Inc. (Invitrx) is NOT liable for the intended use of any of its products. Invitrx does not intend to define, suggest, alter or approve of any kind of "practice of medicine" performed by the administering physician(s) instead relying on the IND and/or Clinical Trial IRB to determine safe practices of use of the Cord Blood Stem Cell Product(s)(CBSC), Amniotic Fluid, Amniotic Tissue, Human Umbilical Cord Blood Plasma (hUCBP), Wharton's Jelly, and Wharton's Jelly (MSC).
People
Description
Invitrx Therapeutics, Inc. (Invitrx) is NOT liable for the intended use of any of its products. Invitrx does not intend to define, suggest, alter or approve of any kind of "practice of medicine" performed by the administering physician(s) instead relying on the IND and/or Clinical Trial IRB to determine safe practices of use of the Cord Blood Stem Cell Product(s)(CBSC), Amniotic Fluid, Amniotic Tissue, Human Umbilical Cord Blood Plasma (hUCBP), Wharton's Jelly, and Wharton's Jelly (MSC).

Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link